iPASy is revolutionizing prostate cancer screening with a urine-based, non-invasive diagnostic that detects disease-specific glycan patterns of urinary PSA, offering up to six-times higher specificity than blood-based tests. Our vision is to make prostate cancer detection accurate, accessible, and p...